Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (SKIN), innovator of Hydrafacial systems and advanced aesthetic technologies since 1997, provides this centralized hub for investors and industry professionals. Our news collection offers immediate access to verified corporate developments, combining regulatory filings with market analysis for complete transparency.
This resource serves as your primary source for tracking earnings announcements, product innovations, and strategic partnerships that shape the medical aesthetics sector. Users benefit from chronological organization of press releases alongside third-party analyses, maintaining balanced perspectives on company milestones.
Content spans critical updates including FDA clearances, international expansion efforts, and clinical study results. Each entry is vetted for relevance to investor priorities and industry trends, with particular emphasis on the company's serum-based technology advancements.
Bookmark this page for real-time updates on SKIN's market movements and professional-grade insights into the $18B global aesthetics industry. Cross-reference our archive with SEC filings using provided document identifiers for complete due diligence capabilities.
The Beauty Health Company (NASDAQ: SKIN) announced that CEO Andrew Stanleick and CFO Liyuan Woo will present at two upcoming investor conferences. The 43rd Annual Institutional Investors Conference hosted by Raymond James is scheduled for
BeautyHealth (NASDAQ: SKIN) reported Q4 2021 net sales of $77.9 million, a 105.6% increase from Q4 2020. For FY 2022, the company expects net sales between $320 million to $330 million and adjusted EBITDA around $50 million. Despite a net loss of $17.3 million in Q4 2021, adjusted EBITDA rose to $8.5 million, up from $3.6 million in Q4 2020. Cash and equivalents surged to $901.9 million, largely from a $638.7 million convertible senior notes offering. The company aims to leverage its investments and achieve historical profitability margins by 2023.
The Beauty Health Company (NASDAQ:SKIN) will release its fourth quarter and full-year fiscal 2021 financial results on February 22, 2022, after market close. A conference call to discuss the results will be held at 4:30 p.m. Eastern Time on the same day. Investors can join by calling (877) 407-9208 or accessing a live audio webcast at their investor relations page.
BeautyHealth focuses on innovative beauty health products, with its flagship HydraFacial brand available in over 87 countries and performing millions of treatments annually.
The BeautyHealth Company has opened its 9th global HydraFacial HFX Experience Center in New York City. Launched in 2018, the HydraFacial HFX program enhances aesthetic professionals' skills with a focus on client engagement, protocols, and marketing techniques. Key benefits include increased client retention, upselling confidence, and business growth strategies. With over 19,000 Delivery Systems in 87 countries, HydraFacial aims to democratize skincare with its innovative treatments. This move reinforces the company's commitment to education in the beauty health sector.
The Beauty Health Company (NASDAQ:SKIN) announced the appointment of Andrew Stanleick as President and CEO, effective February 7, 2022. With over 25 years of experience in the beauty and retail sectors, Stanleick aims to enhance the company’s growth trajectory, particularly in Asia. Previously, he held senior roles at Coty and Coach, and his track record includes overseeing high-profile brands. The executive transition comes as the company seeks to leverage digital marketing and expand its global footprint, particularly with its flagship product, HydraFacial.
The Beauty Health Company (NASDAQ:SKIN) has updated its fiscal year 2021 outlook, expecting net sales to be near the high end of previous guidance at $245 million to $255 million. The company also reiterates its adjusted EBITDA expectation of approximately $30 million. Despite facing challenges from a new COVID variant, BeautyHealth's Executive Chairman, Brent Saunders, noted resilient growth and opportunities in the beauty health sector. Risks include potential impacts from market closures and rising costs.
The Beauty Health Company (NASDAQ:SKIN) has appointed Kellie Sears as its new Chief Human Resources Officer, effective immediately. With extensive global experience, Sears will lead human capital management, focusing on talent acquisition, diversity, and employee engagement. Executive Chairman Brent Saunders expressed optimism about Sears' impact on the company’s growth strategy. Previously, she held HR leadership roles at major companies including Allergan and Pfizer. BeautyHealth aims to strengthen its global workforce to support its successful HydraFacial brand, enhancing its market position.
The Beauty Health Company (NASDAQ:SKIN) announced that CFO Liyuan Woo will join a virtual fireside chat at the 2022 ICR Conference on January 11, 2022, at 9:30 am ET.
This event will be webcast live on the company's investor relations website, with an archived replay available later. BeautyHealth is known for its HydraFacial brand, which offers non-invasive skincare solutions using patented technology.
The Beauty Health Company (NASDAQ:SKIN) concludes its 2021 #GLOWvolution Tour this weekend in Times Square, after successfully traveling across the U.S. since June. The tour provided free HydraFacial treatments to thousands, significantly increasing brand engagement and social media impressions. The initiative extended beyond consumer engagement, offering educational resources for HydraFacialists. The success of the tour led to the addition of the NYC stop, showcasing the positive reception from the public and professionals in the beauty industry.
The Beauty Health Company (NASDAQ:SKIN) announced that Brent Saunders, Executive Chairman, and Liyuan Woo, CFO, will present at Piper Sandler’s 33rd Annual Virtual Healthcare Conference on November 22, 2021, at 10:00 a.m. ET. A webcast of the presentation will be available on the Company’s investor relations website, with an archived replay accessible afterward.
BeautyHealth focuses on innovative beauty products, with its flagship HydraFacial offering a non-invasive skin care solution available in over 87 countries.